Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 15Breast 7Thoracic 6Genitourinary 6Gastrointestinal 6Head & Neck 4Dermatologic 4Other solid neoplasm 3Sarcoma 2Endocrine 1CNS 1

Conditions

Brain Neoplasms 24Melanoma 19Glioblastoma 13Neuroblastoma 6Glioma 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Transitional Cell 3Carcinoma, Renal Cell 3Wilms Tumor 2Seminoma 2Rhabdomyosarcoma 2Osteosarcoma 2Neoplasm Metastasis 2Meningioma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Hodgkin Disease 2Gliosarcoma 2Central Nervous System Neoplasms 2Astrocytoma 2Xeroderma Pigmentosum 1Vulvar Neoplasms 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1

Interventions

Filgrastim 12Carboplatin 10Paclitaxel 9Peripheral Blood Stem Cell Transplantation 7Cyclophosphamide 7Ifosfamide 6Temozolomide 5Cisplatin 5pembrolizumab 4Nivolumab 4Gemcitabine 4Etoposide 4Docetaxel 4fludarabine 3Thiotepa 3Specimen Handling 3Psychiatric Rehabilitation 3Melphalan 3Magnetic Resonance Spectroscopy 3Immunologic Techniques 3Fluorodeoxyglucose F18 3Flow Cytometry 3Bevacizumab 3Amifostine 3ulixertinib 2trametinib 2sargramostim 2sapanisertib 2pegfilgrastim 2ixabepilone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Ipilimumab × CNS × Clear all
NCT04434560 2022-07-26

Neoadjuvant Immunotherapy in Brain Metastases

Duke University

Phase 2 Terminated
1 enrolled 7 charts
BreastCNSDermatologicGenitourinaryGynecologicThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Melanoma, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡